135 related articles for article (PubMed ID: 7509890)
1. [Lung residuals following chemotherapy in patients with stage III nonseminomatous testicular cancer. Report of 4 cases].
Ueda T; Yamauchi T; Kawai T; Ohno Y; Kawakami S; Yonese J; Tachibana Y
Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):350-3. PubMed ID: 7509890
[TBL] [Abstract][Full Text] [Related]
2. BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG).
Germà-Lluch JR; Garcia del Muro X; Tabernero JM; Sánchez M; Aparicio J; Alba E; Barnadas A
Ann Oncol; 1999 Mar; 10(3):289-93. PubMed ID: 10355572
[TBL] [Abstract][Full Text] [Related]
3. [A case of testicular choriocarcinoma achieving pathological complete response by "COMPE" chemotherapy, consisting of cisplatin, vincristine, methotrexate, peplomycin, and etoposide].
Ohno Y; Yamauchi T; Ueda T; Aizawa T; Kawakami S; Tachibana Y; Kawai T; Nakagawa K; Tsuchiya S
Hinyokika Kiyo; 1993 Feb; 39(2):183-7. PubMed ID: 7682032
[TBL] [Abstract][Full Text] [Related]
4. [Low dose COMPE. Cisplatin, vincristine, methotrexate, peplomycin, etoposide chemotherapy for advanced testicular cancer].
Ueda T; Yamauchi T; Kawai T; Ohono Y; Kawakami S; Yonese J
Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):626-31. PubMed ID: 7514699
[TBL] [Abstract][Full Text] [Related]
5. [A case of stage IIIB2 infantile yolk sac tumor of testis achieved complete remission by "COMPE" chemotherapy].
Ueda T; Yamauchi T; Kokuho M; Ishibashi K; Kawakami S; Yonese J; Kawai T
Hinyokika Kiyo; 1993 Dec; 39(12):1183-6. PubMed ID: 7506867
[TBL] [Abstract][Full Text] [Related]
6. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
7. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
8. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
9. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
[TBL] [Abstract][Full Text] [Related]
10. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.
Gels ME; Hoekstra HJ; Sleijfer DT; Nijboer AP; Molenaar WM; Ebels T; Schraffordt Koops H
Chest; 1997 Oct; 112(4):967-73. PubMed ID: 9377960
[TBL] [Abstract][Full Text] [Related]
11. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
12. Optimal number of chemotherapy courses in advanced nonseminomatous testicular carcinoma.
Kennedy BJ; Torkelson J; Fraley EE
Am J Clin Oncol; 1995 Dec; 18(6):463-8. PubMed ID: 8526185
[TBL] [Abstract][Full Text] [Related]
13. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
[TBL] [Abstract][Full Text] [Related]
14. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
15. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in pathologic Stage II nonseminomatous testicular cancer: are two cycles of etoposide-cisplatin a standard option?
Culine S; Droz JP
J Clin Oncol; 1996 Jul; 14(7):2187-8. PubMed ID: 8683254
[No Abstract] [Full Text] [Related]
17. [Complete remission obtained in advanced testicular cancer treated by etoposide (NK-171)].
Babaya K; Tsumatani K; Natsume O; Yoshie T; Kubota K; Ozono S; Hirao Y; Okajima E
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):604-7. PubMed ID: 2420282
[TBL] [Abstract][Full Text] [Related]
18. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
[TBL] [Abstract][Full Text] [Related]
19. Postchemotherapy surgery in nonseminomatous testicular tumors.
Hornák M; Ondrus D; Matoska J; Cársky S
Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
[TBL] [Abstract][Full Text] [Related]
20. Thoracotomy as a staging procedure after chemotherapy in the treatment of Stage III nonseminomatous carcinoma of the testis.
Prenger K; Eysman L; van der Heide JN; Oldhoff J; Sleijfer DT; Koops HS; Oosterhuis JW
Ann Thorac Surg; 1984 Nov; 38(5):444-6. PubMed ID: 6208857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
